Centre for Sight announced that Medical Director Sheraz Daya, MD, has successfully performed the first implantation in England of the Bausch + Lomb's new enVista Envy IOL.

The enVista Envy IOL builds on B+L's enVista platform with a next-generation design that provides patients with a full range of high-quality vision. Its ActivSync optic and ClearPath technology intelligently distribute light to enhance image contrast in bright lighting while supporting optimal distance vision in dim conditions. Designed to offer a smooth, continuous focus at near, intermediate and far distances, the lens delivers visual clarity and stability. It also aims to reduce the risk of unwanted visual side-effects, such as glare, halos or starbursts.

“Being able to offer our patients the latest lens technology is incredibly rewarding. The enVista Envy lens provides exceptional visual quality with fewer unwanted light effects, which can make a real difference to everyday life," said Dr. Daya, Founder and Medical Director of Centre for Sight. "I am pleased to introduce this advancement in England and grateful to our team for their dedication to delivering world-class care.”